New drugs make treatment of CLL like a chronic disease

FDA Approves Zanubrutinib for CLL and SLL - NCI

The emergence of newer drugs for CLL like zanubrutinib is “making a good thing even better,” Dr. Wiestner continued. A better BTK inhibitor? CLL ...

Patients diagnosed with chronic lymphocytic leukemia who are treated with new targeted agents may have a normal life span, according to John ...

Targeted Therapy Drugs for Chronic Lymphocytic Leukemia

Pirtobrutinib is a newer type of BTK inhibitor that works in a slightly different way. It can be used to treat CLL, typically after other ...

New Treatments for Chronic Lymphocytic Leukemia - PMC

Other chemotherapy drugs used are chlorambucil, bendamustine, pentostatin or cladribine, rituximab, ofatumumab, and alemtuzumab. Although chlorambucil is a ...

New Class of Drugs for CLL on the Horizon - Patient Power

Often now, he notes, CLL patients are treated with BTK inhibitors plus another drug such as venetoclax (Venclexta) or rituximab immunotherapy, ...

What's New in Chronic Lymphocytic Leukemia Research?

Newer, targeted drugs are an important part of treatment for most people with CLL. These medicines affect parts of the leukemia cells that make ...

Study finds new potential therapy option for patients with chronic ...

Researchers continue to refine and improve targeted drug therapies that have changed the most common form of adult leukemia – from an ...

New Drugs Make Treatment of CLL Like a Chronic Disease

“Ibrutinib was the first orally available targeted agent approved in CLL patients, and since then we had a second drug approval with the PI3K ...

New Compound Takes Aim at CLL - InventUM - University of Miami

Patients with chronic lymphocytic leukemia (CLL) and related blood cancers are often prescribed targeted drugs called BTK (Bruton's tyrosine ...

FDA approves zanubrutinib for chronic lymphocytic leukemia or ...

On January 19, 2023, the Food and Drug Administration (FDA) approved zanubrutinib (Brukinsa, BeiGene USA, Inc.) for chronic lymphocytic ...

Old and New Drugs for Chronic Lymphocytic Leukemia

Several novel treatments for chronic lymphocytic leukemia (CLL) have been recently approved based on the results of randomized clinical ...

Treatment options for chronic lymphocytic leukaemia (CLL)

The main treatments for chronic lymphocytic leukaemia are targeted cancer drugs. You might have a combination of a targeted cancer drug with other anti ...

New and Breakthrough Treatment Options for CLL - Healthline

Targeted therapies · zanubrutinib (Brukinsa): Approved by the Food and Drug Administration (FDA) in 2023, zanubrutinib targets the enzyme known as Bruton's ...

10 Years in CLL: Top Advances From 2012-2022 - Targeted Oncology

The past decade has seen the FDA approve a handful of new targeted therapies for chronic lymphocytic leukemia that are prompting a move ...

New drug treatment for CLL and NHL showing promise | Ohio State ...

A new drug treatment for chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL) is showing promise during clinical trials.

U.S. FDA Approves Bristol Myers Squibb's Breyanzi ® as the First ...

U.S. FDA Approves Bristol Myers Squibb's Breyanzi ® as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Chronic ...

New Drug Combination Shows Promise for CLL - NCI

Venetoclax (Venclexta) and rituximab (Rituxan) substantially improved progression-free survival in chronic lymphocytic leukemia (CLL) ...

FDA Approves New Drug for the Most Common Form of Leukemia in ...

Rye Brook, N.Y., December 8, 2023 – The U.S. Food and Drug Administration has approved pirtobrutinib (Jaypirca™) for the treatment of adults with chronic ...

Winning combination of drugs for treating Chronic Lymphocytic ...

Much more effective · Winning team · Stopping and restarting treatment · CLL as a chronic disease · New studies.

Medical Treatments for Chronic Lymphocytic Leukemia

Some of the chemotherapy drugs traditionally used to treat chronic lymphocytic leukemia include fludarabine, cyclophosphamide, and dexamethasone. Newer ...